Optimism Grows in the Fight Against Cancer as Breakthroughs and Funding Increase
Unpleasant Surprises Could Be In Store For Nurix Therapeutics, Inc.'s (NASDAQ:NRIX) Shares
Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit
Baird Initiates Nurix Therapeutics(NRIX.US) With Buy Rating, Announces Target Price $26
Nurix Therapeutics Showcases Breakthrough BTK Degraders
Nurix Therapeutics, Inc. (NRIX): This Small-Cap Healthcare Stock Is A Good Buy Right Now
Nurix Therapeutics to Participate in Upcoming Investor Conferences
Insider Sale: CFO Houte Van Sells 20,000 Shares of Nurix Therapeutics Inc (NRIX)
Nurix Therapeutics Insider Sold Shares Worth $504,370, According to a Recent SEC Filing
Oppenheimer Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $27
Express News | Nurix Therapeutics : Oppenheimer Raises Target Price to $27 From $25
TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Express News | Oppenheimer Maintains Outperform on Nurix Therapeutics, Raises Price Target to $27
Express News | Nurix Therapeutics Shares Are Trading Higher After Truist Securities Initiated Coverage on the Stock With a Buy Rating and Announced a Price Target of $36
Forecasting The Future: 13 Analyst Projections For Nurix Therapeutics
Nurix Therapeutics Initiated at Buy by Truist Securities
Truist Financial Initiates Nurix Therapeutics(NRIX.US) With Buy Rating, Announces Target Price $36
Express News | Nurix Therapeutics Inc : Truist Securities Initiates With Buy Rating; Price Target $36
Stifel Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $30
Stifel Nicolaus Sticks to Their Buy Rating for Nurix Therapeutics (NRIX)